Please login to the form below

Not currently logged in

New CSO for Sanofi

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer, effective September 1, 2011

Sanofi has appointed Dr David-Alexandre Gros as the pharmaceutical company's new chief strategy officer effective, September 1, 2011.

Based in Paris, France, Gros will oversee all Sanofi's business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management.

He will report to Sanofi's' CEO, Christopher A Viehbacher.

Commenting on the appointment, Viehbacher said: "David-Alexandre brings a wealth of experience as a physician, strategic consultant and investment banker. He will be able to contribute significantly to the development and implementation of Sanofi's strategy and transformation."

Gros' previous positions include acting as an advisor to healthcare companies as principal of the healthcare investment banking division at Centerview Partners, as well as holding senior positions at Merrill Lynch and McKinsey & Company.

He was also resident physician at the University of Pennsylvania Health System from 1999 to 2000.

30th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...